AFEYAN NOUBAR

PrivateCIK: 1222012

Location

CAMBRIDGE, MA

AFEYAN NOUBAR enters GENERATE BIOMEDICINES, INC. with 25.02M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Indirect Derivatives

AFEYAN NOUBAR

Filed: 2/26/2026ACC: 0001193125-26-078738

InsiderAFEYAN NOUBARCIK 1222012

→

IssuerGENERATE BIOMEDICINES, INC.CIK 2100782

Director10% Owner

Since Feb 2026

25.02M

Baseline shares

0.00

Direct ownership

0 positions

33.03M

Derivative underlying

12 instruments

1

Security positions

25.02M indirect

Non-Derivative Holdings1

Common Stock

Indirect

Shares owned25.02M

Total

25.02M indirect25.02M

Security Title	Shares Owned	Ownership Type
Common Stock	25.02M	Indirect
Total	25.02M	25.02M indirect

Derivative Holdings12

Series A Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

11.20M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series A Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

12.17M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series A Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

987.49K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series B Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

1.39M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series B Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

1.94M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series B Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

833.33K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series B Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

555.55K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series C Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

1.67M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series C Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

1.39M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series C Preferred Stock

Indirect

Underlying security

Common Stock

Underlying shares

833.33K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

32.92K

Shares owned

N/A

Exercise price

7.25

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

32.92K

Shares owned

N/A

Exercise price

9.15

Expiration

—

Exercise window

—

Total

Underlying

33.03M

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Series A Preferred Stock Indirect	Common Stock		—	—	11.20M	N/A
Series A Preferred Stock Indirect	Common Stock		—	—	12.17M	N/A
Series A Preferred Stock Indirect	Common Stock		—	—	987.49K	N/A
Series B Preferred Stock Indirect	Common Stock		—	—	1.39M	N/A
Series B Preferred Stock Indirect	Common Stock		—	—	1.94M	N/A
Series B Preferred Stock Indirect	Common Stock		—	—	833.33K	N/A
Series B Preferred Stock Indirect	Common Stock		—	—	555.55K	N/A
Series C Preferred Stock Indirect	Common Stock		—	—	1.67M	N/A
Series C Preferred Stock Indirect	Common Stock		—	—	1.39M	N/A
Series C Preferred Stock Indirect	Common Stock		—	—	833.33K	N/A
Stock Option (Right to Buy) Direct	Common Stock	7.25	—	—	32.92K	N/A
Stock Option (Right to Buy) Direct	Common Stock	9.15	—	—	32.92K	N/A
Total					33.03M	0.00

AFEYAN NOUBAR — Initial Ownership Disclosure (Form 3) Filed Feb 26, 2026 | Finecho